REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
9.73
-0.52 (-5.07%)
Jul 24, 2026, 4:00 PM EDT - Market closed
REGENXBIO Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -290.01 | -193.88 | -227.1 | -263.49 | -280.32 | 127.84 |
Depreciation & Amortization | 15.52 | 15.62 | 16.22 | 17.32 | 12.91 | 9.56 |
Stock-Based Compensation | 34.64 | 34.56 | 38.46 | 40.27 | 40.79 | 38.81 |
Other Adjustments | 12.27 | 7.96 | -6.23 | -1.61 | 5.16 | 2.45 |
Change in Receivables | 9.02 | -7.66 | 9.71 | 3.94 | 4.82 | 14.12 |
Changes in Accounts Payable | 1.72 | -2.28 | -0.29 | -2.79 | 18.79 | -2.3 |
Changes in Accrued Expenses | -2.02 | 0.23 | -12.12 | 2.45 | -25.62 | 29.91 |
Changes in Unearned Revenue | -11.19 | 29.28 | -0.03 | -1.51 | -1.17 | -0.9 |
Changes in Other Operating Activities | -3.66 | -7.78 | 8.28 | -12.97 | 17.15 | -0.61 |
Operating Cash Flow | -233.78 | -123.96 | -173.13 | -218.41 | -207.49 | 218.88 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Capital Expenditures | -2.63 | -2.41 | -2.44 | -9.96 | -30.72 | -84.18 |
Purchases of Investments | -323.31 | -332.63 | -190.14 | -86.56 | -184.88 | -498.14 |
Proceeds from Sale of Investments | 335.85 | 319.18 | 296.02 | 287.47 | 203.67 | 175.68 |
Investing Cash Flow | 9.98 | -15.87 | 103.45 | 190.94 | -11.93 | -406.64 |
Long-Term Debt Issued | - | 144.49 | - | - | - | -0.27 |
Long-Term Debt Repaid | -35.88 | -28.1 | -39.85 | -42.3 | -33.1 | -26.59 |
Net Long-Term Debt Issued (Repaid) | -35.88 | 116.4 | -39.85 | -42.3 | -33.1 | -26.86 |
Issuance of Common Stock | 1.26 | 1.01 | 133.45 | 7.75 | 4.55 | 222.11 |
Repurchase of Common Stock | -0.95 | -0.63 | -0.91 | -0.42 | -0.28 | -0 |
Net Common Stock Issued (Repurchased) | 0.31 | 0.38 | 132.54 | 7.33 | 4.26 | 222.11 |
Financing Cash Flow | 108.93 | 116.77 | 92.68 | -34.97 | -28.84 | 195.25 |
Net Cash Flow | -114.88 | -23.06 | 23 | -62.43 | -248.26 | 7.48 |
Free Cash Flow | -236.4 | -126.38 | -175.56 | -228.37 | -238.21 | 134.7 |
Free Cash Flow Growth | - | - | - | - | - | - |
FCF Margin | -269.18% | -74.15% | -210.69% | -253.06% | -211.32% | 28.64% |
Free Cash Flow Per Share | -4.56 | -2.45 | -3.55 | -5.22 | -5.52 | 3.07 |
Levered Free Cash Flow | -328.15 | -44.84 | -257.35 | -313.25 | -322.08 | 52.47 |
Unlevered Free Cash Flow | -258.95 | -128.56 | -223.74 | -275.44 | -271.46 | 96.28 |